Clinical Trial Update: Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of adipose-derived mesenchymal stem cell transplantation for Type 1 Diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Adipose-Derived Mesenchymal Stem Cell Transplantation

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED